H.Y. Ahn, J.E. Chae, H. Moon, J. Noh, Y.J. Park, S.G. Kim, Trends in the diagnosis and treatment of patients with medullary thyroid carcinoma in Korea. Endocrinol. Metab. 35, 811–819 (2020).
K. Kaliszewski, M. Ludwig, B. Ludwig, A. Mikuła, M. Greniuk, J. Rudnicki, Update on the diagnosis and management of medullary thyroid cancer: what has changed in recent years?. Cancers 14, 3643 (2022).
Article CAS PubMed PubMed Central Google Scholar
S. Roman, R. Lin, J.A. Sosa, Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107, 2134–2142 (2006).
S.A. Wells, S.L. Jr., Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack,, Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567–610 (2015).
R.W. Randle, C.J. Balentine, G.E. Leverson, J.A. Havlena, R.S. Sippel, D.F. Schneider, S.C. Pitt, Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017).
E.M. Opsahl, L.A. Akslen, E. Schlichting, T. Aas, K. Brauckhoff, A.I. Hagen, A.F. Rosenlund, E. Sigstad, K.K. Grøholt, L. Mæhle, L.F. Engebretsen, L.H. Jørgensen, J.E. Varhaug, T. Bjøro, Trends in diagnostics, surgical treatment, and prognostic factors for outcomes in medullary thyroid carcinoma in Norway: a nationwide population-based study. Eur. Thyroid. J. 8, 31–40 (2019).
Article CAS PubMed Google Scholar
C.M. Oh, K.W. Jung, Y.J. Won, A. Shin, H.J. Kong, J.S. Lee, Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res. Treat. 47, 362–369 (2015).
Article CAS PubMed Google Scholar
Z. Wang, X. Fan, X. Zha, Y. Xu, Z. Yin, Y. Rixiati, F. Yu, A proposed modified staging system for medullary thyroid cancer: a SEER analysis with multicenter validation. Oncologist 29, e59–e67 (2024).
J.S. Mathiesen, J.P. Kroustrup, P. Vestergaard, P.L. Poulsen, ÅK. Rasmussen, U. Feldt-Rasmussen, S. Schytte, S.C. Londero, H.B. Pedersen, C.H. Hahn, J. Bentzen, S. Möller, M. Gaustadnes, M. Rossing, F.C. Nielsen, K. Brixen, C. Godballe, Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr. Connect. 8, 1–7 (2019).
M.F. Saad, N.G. Ordonez, R.K. Rashid, J.J. Guido, C.S. Hill Jr., R.C. Hickey, N.A. Samaan, Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 63, 319–342 (1984).
Article CAS PubMed Google Scholar
E. Kebebew, P.H. Ituarte, A.E. Siperstein, Q.Y. Duh, O.H. Clark, Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88, 1139–1148 (2000).
Article CAS PubMed Google Scholar
A. Mantovani, P. Allavena, A. Sica, F. Balkwill, Cancer-related inflammation. Nature 454, 436–444 (2008).
Article CAS PubMed Google Scholar
E. Elinav, R. Nowarski, C.A. Thaiss, B. Hu, C. Jin, R.A. Flavell, Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759–771 (2013).
Article CAS PubMed Google Scholar
D. Kuroda, H. Sawayama, J. Kurashige, M. Iwatsuki, T. Eto, R. Tokunaga, Y. Kitano, K. Yamamura, M. Ouchi, K. Nakamura, Y. Baba, Y. Sakamoto, Y. Yamashita, N. Yoshida, A. Chikamoto, H. Baba, Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21, 204–212 (2018).
K. Migita, T. Takayama, K. Saeki, S. Matsumoto, K. Wakatsuki, K. Enomoto, T. Tanaka, M. Ito, N. Kurumatani, Y. Nakajima, The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann. Surg. Oncol. 20, 2647–2654 (2013).
J. Ignacio de Ulíbarri, A. González-Madroño, N.G. de Villar, P. González, B. González, A. Mancha, F. Rodríguez, G. Fernández, CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr. Hosp. 20, 38–45 (2005).
S. Kheirouri, M. Alizadeh, Prognostic potential of the preoperative controlling nutritional status (CONUT) score in predicting survival of patients with cancer: a systematic review. Adv. Nutr. 12, 234–250 (2021).
Article CAS PubMed Google Scholar
M.K.M. Shakir, A.J. Spiro, V.Q. Mai, T.D. Hoang, Diarrhea as an initial presentation in patients with medullary thyroid cancer: delaying the diagnosis. Case Rep. Gastroenterol. 14, 391–401 (2020).
Article PubMed PubMed Central Google Scholar
M.C. Pais, T. Maia, A. Peixoto, L. Meira, A. Albuquerque, J. Lopes, J. Capela, Diarrhea as a form of presentation of medullary thyroid carcinoma. Porto Biomed. J. 3, e18 (2018).
Article PubMed PubMed Central Google Scholar
S. Filetti, C. Durante, D. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti, A. Berruti, Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann. Oncol. 30, 1856–1883 (2019).
Article CAS PubMed Google Scholar
A. Machens, H. Dralle, Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J. Clin. Endocrinol. Metab. 95, 2655–2663 (2010).
Article CAS PubMed Google Scholar
M. Mantzorou, A. Koutelidakis, S. Theocharis, C. Giaginis, Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis?. Nutr. Cancer 69, 1151–1176 (2017).
T. Akamine, G. Toyokawa, T. Matsubara, Y. Kozuma, N. Haratake, S. Takamori, M. Katsura, K. Takada, F. Shoji, T. Okamoto, Y. Maehara, Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung disease. Anticancer. Res. 37, 2735–2742 (2017).
N. Harimoto, T. Yoshizumi, S. Inokuchi, S. Itoh, E. Adachi, Y. Ikeda, H. Uchiyama, T. Utsunomiya, K. Kajiyama, K. Kimura, F. Kishihara, K. Sugimachi, E. Tsujita, M. Ninomiya, K. Fukuzawa, T. Maeda, K. Shirabe, Y. Maehara, Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma: a multi-institutional study. Ann. Surg. Oncol. 25, 3316–3323 (2018).
N. Hirahara, Y. Tajima, Y. Fujii, S. Kaji, Y. Kawabata, R. Hyakudomi, T. Yamamoto, T. Taniura, Controlling Nutritional Status (CONUT) as a prognostic immunonutritional biomarker for gastric cancer after curative gastrectomy: a propensity score-matched analysis. Surg. Endosc. 33, 4143–4152 (2019).
Y. Huang, Y. Huang, M. Lu, W. Sun, X. Sun, X. Chen, L. Li, A. Chandoo, L. Li, Controlling nutritional status (CONUT) score is a predictor of post-operative outcomes in elderly gastric cancer patients undergoing curative gastrectomy: a prospective study. Cancer Manag. Res. 11, 9793–9800 (2019).
Article CAS PubMed PubMed Central Google Scholar
C. Dalmiglio, L. Brilli, M. Campanile, C. Ciuoli, A. Cartocci, M.G. Castagna, CONUT score: a new tool for predicting prognosis in patients with advanced thyroid cancer treated with TKI. Cancers 14, 724 (2022).
Article CAS PubMed PubMed Central Google Scholar
L. Agate, E. Minaldi, A. Basolo, V. Angeli, R. Jaccheri, F. Santini, R. Elisei, Nutrition in advanced thyroid cancer patients. Nutrients 14, 1298 (2022).
Article CAS PubMed PubMed Central Google Scholar
J.I. de Ulíbarri Pérez, G. Fernández, F. Rodríguez Salvanés, A.M. Díaz López, Nutritional screening; control of clinical undernutrition with analytical parameters. Nutr. Hosp. 29, 797–811 (2014).
E.J. Sherubin, K.S. Kannan, D.N. Kumar, I. Joseph, Estimation of plasma lipids and its significance on histopathological grades in oral cancer: prognostic significance an original research. J. Oral. Maxillofac. Pathol. 17, 4–9 (2013).
Article PubMed PubMed Central Google Scholar
B. Li, D. Huang, H. Zheng, Q. Cai, Z. Guo, S. Wang, Preoperative serum total cholesterol is a predictor of prognosis in patients with renal cell carcinoma: a meta- analysis of observational studies. Int. Braz. J. Urol. 46, 158–168 (2020).
Comments (0)